% CI,
1.2-5.1). The 30-day incidence of disabling stroke or death
was 1.5% after CEA (95% CI, 0.5-4.2) and 3.4% after CAS
(95% CI, 1.7-6.7); the RR was 2.2 (95% CI, 0.7-7.2). However,
EVA-3S